Next Article in Journal
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System
Previous Article in Journal
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(3), 355; https://doi.org/10.3390/ph17030355
Action Date Notes Link
article xml file uploaded 9 March 2024 09:21 CET Original file -
article xml uploaded. 9 March 2024 09:21 CET Update https://www.mdpi.com/1424-8247/17/3/355/xml
article pdf uploaded. 9 March 2024 09:21 CET Version of Record https://www.mdpi.com/1424-8247/17/3/355/pdf
article supplementary file uploaded. 9 March 2024 09:21 CET - https://www.mdpi.com/1424-8247/17/3/355#supplementary
article html file updated 9 March 2024 09:22 CET Original file https://www.mdpi.com/1424-8247/17/3/355/html
Back to TopTop